Drug Development Services Australia

We leverage our experience to share unique perspectives and ultimately deliver your quality results. Together, we can reveal opportunities and advance your innovation.

• 临床试验支持：Improve operational efficiencies and accelerate your timeline with our streamlined start-up process.
  • Early clinical/phase IIa
    • 临床药理学
    • 早期患者研究
    • Clinical Trial Project Management and Monitoring
    • 概念证明
  • 阶段IIB / III
    • Xcellerate^®临床试验优化^®
    • Clinical Trial Management
    • Xcellerate^®Monitoring
    • Drug Safety
    • 功能服务提供商
  • 生命周期管理
  • Clinical Data Analysis and Reporting
  • Regulatory
• 卫生经济学与结果研究：传达产品的价值，并开发现实世界和建模证据支持的强大报销申请。

利用亚太地区邻近地区的发展解决方案：

• 非临床发展服务：Leverage our dedicated expertise and operations across the region to deliver unique perspectives on your development program. Our CFDA GLP certified facility in Shanghai, China features a number of accreditations to fulfill global quality standards (FDA, OECD, etc.). Specific solutions for small molecules and biologics are available to reduce costs and gain efficiencies for your project.
• Clinical Testing Services:信任新加坡中央实验室的经验提供一致的质量数据。自2000年以来经营，我们提供世界上最大的中央实验室之一，在亚太地区提供16个国家。

我们在一起，我们各种各样的当地科学专家网络可以在任何药物开发阶段满足您的全球需求，并帮助您到达决策点。

• 全球一致性：从我们的全球SOP和最佳实践获得统一的质量标准。
• 监管支持：Obtain regulatory approval and benefit from low compliance costs for a faster start-up time.

澳大利亚强大的贸易链接，专门的研究机构和受过良好教育，多语种劳动力使其成为向前移动研究的经过验证的目的地。考虑以下优点，为您的临床试验：

• Proximity to emerging markets：澳大利亚是在东南亚新兴市场的地区提供战略平台。
• International harmonization：The Australian clinical environment is aligned with Food and Drug Administration (FDA) and International Conference on Harmonization/Good Clinical Practice (ICH/GCP) standards.
• 季节性研究：The “reverse seasons” in Australia enable year-round international studies for more rapid development of products.

With our unique combination of regional knowledge and global experience, we’re ready to work together and explore what’s possible. Learn more about how we can deliver your results.